2017, Number 3
<< Back Next >>
Rev Mex Neuroci 2017; 18 (3)
Standardization of the six-minute walk test in healthy mexican children
Blanco HG, Hernández RHG, Esmer C, Castro GS, Núñez BE, Bravo OA
Language: Spanish
References: 30
Page: 11-23
PDF size: 161.37 Kb.
ABSTRACT
Objective. The six-minute walk test has been used to assess
the functional status of patients with cardiopulmonary and
neuromuscular diseases. To obtain the distance in meters for the sixminute
walk test and calculate the percentiles for healthy children
aged 5-14 years. Also, the impact on heart rate, blood pressure and
oxygen saturation was evaluated.
Methods. The test was conducted according to the guidelines of
the ATS. 370 children, 163 women and 207 men were included. Prior
to the test the age, weight and body mass index was recorded. The
distance was measured in meters and heart rate; blood pressure and
oxygen saturation was recorded before and after the test. Age groups
were formed, group 1: 5-6 years 11 months, group 2: 7-9 years 11
months, group 3: 10-12 years 11 months and group 4: 13-14 years 11
months.
Results. The mean walking distance was 545.68 m (±120.55 m) with
a minimum of 335 m and a maximum of 760 m. We found that age,
height, and weight significantly predicts the walking distance, and
it was demonstrated that vital signs are changed minimally during
testing.
Conclusions. The present form of the six-minute walk distance
test is safe, easy, feasible and useful as a comparative measure in the
evaluation of healthy children and adolescents and in monitoring
patients with cardiorespiratory and neuromuscular diseases.
REFERENCES
Balke B. A simple field test for the assessment of physical fitness. Rep Civ Aeromed Res Inst US. 1963; 53:1-8.
Cooper KH. A means of assessing maximal oxygen intake. Correlation between field and treadmill testing. JAMA. 1968; 203: 201-4.
Mcgavin CR, Gupta SP, Mchardy GRJ. Twelve-minute walking test for assessing disability in chronic bronchitis. BMJ.1976; 1: 822–3.
Enright PL. The six-minute walk test. Respir Care. 2003; 48(8): 783–5.
American Thoracic Society. American Thoracic Society statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166: 111–7.
Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systemic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001; 119: 256–70.
Boucault R, Fernandes M, Oliveira Carvalho V. Six-minute walking test in children. Disabil Rehabil. 2013; 35: 1586–7.
Cunha MT, Rozov T, de Oliveira RC, Jardim JR. Six-minute walk test in children and adolescents with cystic fibrosis. Pediatr Pulmonol. 2006; 41: 618–22.
Goemans N, van den Hauwe M, Wilson R, van Impe A, Klingels K, Buyse G. Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids. Neuromuscul Disord. 2013; 23: 618-23.
Mazzone E, Bianco F, Main M, van den Hauwe M, Ash M, de Vries R, et al. Six minute walk test in type III spinal muscular atrophy: A 12 month longitudinal study. Neuromuscul Disord. 2013; 23: 624-8.
Cruz-Anleu ID, Baños-Mejía BO, Galicia-Amor S. Prueba de marcha de seis minutos en niños con enfermedad neuromuscular. Rev Med Inst Mex Seguro Soc. 2013; 51: 674-9.
Vázquez-Cárdenas NA, Ibarra-Hernández F, López-Hernández LB. Administración del Patrimonio de la Beneficencia Pública; Asociación de Distrofia Muscular de Occidente. Diagnóstico y tratamiento con esteroides de pacientes con distrofia muscular de Duchenne: experiencia y recomendaciones para México. Rev Neurol. 2013;57:455-62.
Bravo-Oro A, de la Fuente-Cortez B, Molina-García A, Romero-Díaz V, Rodríguez-Leyva I, Esmer-Sánchez M del C; Grupo Mexicano de Estudio de la Enfermedad de Pompe. Diagnóstico y tratamiento en la enfermedad de Pompe disease. Rev Med Inst Mex Seguro Soc. 2013;51:536-51.
Gochicoa-Rangel L, Mora-Romero U, Guerrero-Zúñiga S, Silva-Cerón M, Cid-Juárez S, VelázquezUncal M et al. Prueba de camina de 6 minutos: recomendaciones y procedimientos. Neumol Cir Torax. 2015 abril-junio;7(2):127-36.
Lammers AE, Adatia I, del Cerro MJ, Díaz G, Freudenthal AH, Freudenthal F, et al. Clasificación funcional de la hipertensión pulmonar en niños: informe del task force pediátrico del Pulmonary Vascular Research Institute (PVRI), Panamá 2011.Pulm Circ. 2011 Apr-Jun; 1 (2): 280-285.
Lammers AE, Hislop AA, Flynn Y, Haworth SG. The 6-minute walk test: normal values for children of 4–11 years of age. Arch Dis Child. 2008; 93: 464–8.
Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer v, et al. Six-Minute walk test in children and adolescents. J Pediatr. 2007; 150: 395-9.
Goemans N, Klingels K, van den Hauwe M, Van Orshoven A, Vanpraet S, Feys H, et al. Test-retest reliability and developmental evolution of the 6-min walk test in Caucasian boys aged 5-12 years. Neuromuscul Disord. 2013; 23: 19-24.
Ben Saad H, Prefaut C, Missaoui R, Mohamed IH, Tabka Z, Hayot M. Reference equation for 6-min walk distance in healthy North African children 6-16 years old. Pediatr Pulmonol. 2009; 44: 316-24.
Li AM, Yin J, Au JT, So HK, Tsang T, Wong E, et al. Standard reference for the six-minute walk test in healthy children aged 7 to 16 years. Am J Respir Crit Care Med. 2007; 176: 174–80.
Priesnitz CV, Rodrigues GH, Stumpf CS, Viapiana G, Cabral CP, Stein RT, et al. Reference values for the 6-min walk test in healthy children aged 6-12 years. Pediatr Pulmonol. 2009; 44:1174–9.
Luna Padrón E, Domínguez Flores MA, Rodríguez Pérez A, Gómez Hernández J. Estandarización de la prueba de caminata de 6 minutos en sujetos mexicanos sanos. Rev Inst Nal Enf Resp Mex. 2000; 13: 205-10
Caffrey D, Miranda JJ, Gilman RH, Davila-Roman VG, Cabrera L, Dowling R, et al. A cross-sectional study of differences in 6-min walk distance in healthy adults residing at high altitude versus sea level. Extrem Physiol Med. 2014; 3: 3.
Pacheco-Rios N, Espitia-Hernández G, Sánchez-Ortiz AO. Caminata de 6 minutos en una población pediátrica de 6 a 12 años de edad derechohabiente del Hospital 1º de Octubre. Neumol Cir Torax. 2013; 72: 147-53.
Ulrich S, Hildenbrand FF, Treder U, Fischler M, Keusch S, Speich R, et al. Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland. BMC Pulm Med. 2013; 5: 13- 49.
Goemans N, Klingels K, van den Hauwe M, Boons S, Verstraete L, Peeters C, et al. Six-minute walk test: reference values and prediction equation inhealthy boys aged 5 to 12 years. PLoS One. 2013 Dec 31;8(12):e84120.
Tonklang N, Roymanee S, Sopontammarak S. Developing standard reference data for Thai children from a six-minute walk test. J Med Assoc Thai. 2011; 94: 470–5.
D’silva C, Vaishali K, Venkatesan P. Six-minute walk test-normal values of school children aged 7–12y in India: a cross-sectional study. Indian J Pediatr. 2012; 79: 597-601.
Klepper SE, Muir N. Reference values on the 6-minute walk test for children living in the United States. Pediatr Phys Ther. 2011; 23: 32–40.
Gatica D, Puppo H, Villaroroel G, San Martín I, Lagos R, Montecino JJ, et al. Valores de referencia test de marcha de seis minutos en niños sanos. Rev Med Chile. 2012; 140: 1023-30